Legacy Capital Wealth Partners’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,513
Closed -$292K 370
2024
Q4
$292K Sell
11,513
-1,120
-9% -$28.4K 0.07% 276
2024
Q3
$315K Sell
12,633
-1,234
-9% -$36.5K 0.06% 266
2024
Q2
$411K Buy
+13,867
New +$385K 0.1% 189
2024
Q1
Sell
-12,932
Closed -$370K 290
2023
Q4
$370K Buy
12,932
+2,835
+28% +$83.3K 0.1% 189
2023
Q3
$374K Buy
+10,097
New +$386K 0.1% 186
2023
Q2
Sell
-9,784
Closed -$357K 193
2023
Q1
$357K Buy
+9,784
New +$309K 0.1% 178

Other funds holding RTO

Legacy Capital Wealth Partners's RTO Position: Q1 2025 in Review

Legacy Capital Wealth Partners sold out of Rentokil (RTO) in Q1 2025, closing a stake of 11,513 shares — an estimated $292K sold.

Legacy Capital Wealth Partners first reported a position in RTO in Q1 2023 and held it in 6 quarters. The position peaked at $411K in Q2 2024. 209 funds tracked by Wall St. Rank hold RTO as of Q1 2025.

  • Legacy Capital Wealth Partners reported no remaining Rentokil position as of Q1 2025 after selling out during the quarter.
  • Legacy Capital Wealth Partners sold 11,513 Rentokil shares in Q1 2025, an estimated $292K.
  • Legacy Capital Wealth Partners first reported a position in Rentokil in Q1 2023 and held it in 6 quarters.
  • Legacy Capital Wealth Partners's Rentokil position peaked at $411K in Q2 2024.
  • 209 funds tracked by Wall St. Rank held Rentokil as of Q1 2025.

Based on Legacy Capital Wealth Partners's 13F filing for Q1 2025, filed 2 May 2025.